NEWS

ME Therapeutics press releases, media coverage and scientific findings

ME THERAPEUTICS RECEIVES SUPPORT TO ADVANCE mRNA THERAPEUTIC CANDIDATES FOR CANCER AND INFLAMMATORY DISEASE

ME THERAPEUTICS ANNOUNCES IT HAS ENGAGED LUCOSKY BROOKMAN LLP TO EXPLORE A LISTING ON THE NASDAQ OR NYSE

ME THERAPEUTICS ANNOUNCES THAT ITS FIRST THERAPEUTIC MRNA CANDIDATE SHOWS ENCOURAGING ANTI-CANCER EFFICACY IN VIVO

ME THERAPEUTICS HOLDINGS INC. APPOINTS CHIEF BUSINESS OFFICER

ME THERAPEUTICS HOLDINGS INC. PROVIDES RESEARCH AND DEVELOPMENT UPDATE AND CORPORATE UPDATE

ME THERAPEUTICS ANNOUNCES THE START OF TESTING OF FIRST MRNA FORMULATIONS FROM NANOVATION THERAPEUTICS COLLABORATION

ME THERAPEUTICS ANNOUNCES NEW COLLABORATION WITH NANOVATION THERAPEUTICS ON ADVANCED THERAPEUTIC MRNA DELIVERY TO MYELOID CELLS

ME THERAPEUTICS HOLDINGS INC. ANNOUNCES THE ADDITION OF TWO NEW CLINICAL CONSULTANTS TO CONTINUE THE ADVANCEMENT OF OUR LEAD ANTI-G-CSF ANTIBODY CANDIDATE TOWARDS A FIRST-IN-HUMAN CLINICAL TRIAL

ME THERAPEUTICS TO PRESENT AT INVESTOR CLUBHOUSE AT THE CANADIAN OPEN AND ATTEND THE 2024 BIO INTERNATIONAL CONVENTION FOR PARTNERING OPPORTUNITIES

ME THERAPEUTICS ANNOUNCES UPCOMING PARTICIPATION IN THE 2024 BLOOM BURTON & CO HEALTH CARE CONFERENCE AND INTERVIEW ON CSE TV

ME THERAPEUTICS ANNOUNCES CLOSING OF NON-BROKERED PRIVATE PLACEMENT

CSE TV: Salim Dhanji on Targeting Immune Suppression in Cancer

Keep up to date by subscribing to our mailing list